Improved Trekker by Convaid Debuts at the International Seating Symposium

dsc_0688

The improved Convaid Trekker, a key pediatric wheelchair in our tilt-in-space portfolio, made its first North American appearance at the 33rd International Seating Symposium (ISS), that brought together over 2,000 international attendees at the Gaylord Opryland Hotel and Convention Center, in Nashville, TN, held this week.

The improved Convaid Trekker is an all-day, tilt-in-space, lightweight wheelchair with the flexibility of 180° reversible seating. The occupant can either face forward or face the caregiver. The Trekker easily separates into two lightweight components – the base and the seating module, which makes compact folding simple. Available with two back module options, back canes only or a solid back system with cushion, the Trekker accepts various brands of adaptive and aftermarket seating to fully accommodate the needs of caregivers and therapists. Variable positioning options allow up to 170° of adjustable recline and up to -5° to +45° of adjustable tilt. Center of gravity is maintained when the user is balanced in the seating module, and it promotes ease of tilting and operation with minimum effort. Convaid’s dedication to continuous new improvements has delivered new features such as individual footplates, a padded footbox and a greater selection of head supports. The Trekker has a transit-ready option, and has met WC19 safety standards for safe transportation.

Prior to the event, Director, Marketing Nanneke Dinklo said, “We are excited to present our tilt-in-space portfolio at ISS this year that consists of the improved Trekker, brand new Kudu and improved Stingray and Rodeo wheelchairs. The improved Trekker takes what our customers knew and loved in the original Trekker to a new level.  It is a great compliment to our line of mobility, seating, standing, walking, transportation and hygiene products at ISS. We equally look forward to learning about new developments in the seating and mobility community.”

R82 Convaid develop and manufacture premium pediatric products typically prescribed for children with mild to moderate involvement of the following conditions:  Autism Spectrum Disorder, Cerebral palsy, Down syndrome, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Spinal Bifida, Osteogenesis Imperfecta, Traumatic Brain Injury, Spinal Cord Injury, Cystic Fibrosis, Mitochondrial Disease, Metabolic Diseases, and Sensory Processing Disorders, among others.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s